In this study, adults with type 1 diabetes initiated a regimen of TI plus insulin degludec after completing the usual-care control group of a randomized trial. Roy Beck, MD, Ph.D., from the JAEB ...

In this study, adults with type 1 diabetes initiated a regimen of TI plus insulin degludec after completing the usual-care control group of a randomized trial. About Mary Ann Liebert, Inc., a Sage ...

For many patients with type 2 diabetes, having to inject basal insulin every day ... as daily dosing with Novo Nordisk's Tresiba (insulin degludec) once per day at controlling blood glucose ...

Beck and colleagues from the JAEB Center for Health Research, Tampa, Florida, USA, highlight the rapid onset of action of inhaled Technosphere Insulin (TI, Afrezza) compare ...

and insulin degludec over 30 weeks and its potential to reduce post-meal hyperglycemia in adults with type 1 diabetes. Click here to read the article now. TI has a more rapid onset of action than ...

The company is conducting five registrational QWINT studies to establish that once-weekly efsitora is not inferior to daily insulin injection ... glargine and insulin degludec, respectively.

This leaflet answers some common questions about Ryzodeg ® 70/30 FlexTouch ®. It does not contain all the available information. It does not take the place of talking to your doctor, diabetes ...

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. You can report side ...